BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12857899)

  • 1. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity.
    Herzer K; Falk CS; Encke J; Eichhorst ST; Ulsenheimer A; Seliger B; Krammer PH
    J Virol; 2003 Aug; 77(15):8299-309. PubMed ID: 12857899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulate HLA class I expression following hepatitis B virus transfection in a hepatocellular carcinoma cell line BEL7405.
    Xu L; Shen Y; Xia M; Miao F; Shen C; Xie W; Zhang J
    Immunol Invest; 2010; 39(6):621-34. PubMed ID: 20653429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis.
    Poole MI; Sorribes I; Jain HV
    Math Biosci; 2018 Dec; 306():186-196. PubMed ID: 30312632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells.
    Salcedo M; Momburg F; Hämmerling GJ; Ljunggren HG
    J Immunol; 1994 Feb; 152(4):1702-8. PubMed ID: 8120379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 induces TAP1 and enhances the transport of MHC class I peptides.
    Zhu K; Wang J; Zhu J; Jiang J; Shou J; Chen X
    Oncogene; 1999 Dec; 18(54):7740-7. PubMed ID: 10618714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
    Falk CS; Steinle A; Schendel DJ
    J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core activates proteasomal activator 28γ expression via upregulation of p53 levels to control virus propagation.
    Kwak J; Tiwari I; Jang KL
    J Gen Virol; 2017 Jan; 98(1):56-67. PubMed ID: 27902328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines.
    Frisan T; Donati D; Cervenak L; Wilson J; Masucci MG; Bejarano MT
    Int J Cancer; 1999 Dec; 83(6):772-9. PubMed ID: 10597194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells.
    Hershkovitz O; Zilka A; Bar-Ilan A; Abutbul S; Davidson A; Mazzon M; Kümmerer BM; Monsoengo A; Jacobs M; Porgador A
    J Virol; 2008 Aug; 82(15):7666-76. PubMed ID: 18508882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice.
    Satoh K; Takahashi H; Matsuda C; Tanaka T; Miyasaka M; Zeniya M; Kohara M
    J Med Virol; 2010 Sep; 82(9):1545-53. PubMed ID: 20648608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome).
    Zimmer J; Donato L; Hanau D; Cazenave JP; Tongio MM; Moretta A; de la Salle H
    J Exp Med; 1998 Jan; 187(1):117-22. PubMed ID: 9419217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors.
    Terrazzano G; Zanzi D; Palomba C; Carbone E; Grimaldi S; Pisanti S; Fontana S; Zappacosta S; Ruggiero G
    J Leukoc Biol; 2002 Aug; 72(2):305-11. PubMed ID: 12149421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis.
    Kim H; Bose SK; Meyer K; Ray R
    J Virol; 2014 Mar; 88(5):2564-71. PubMed ID: 24352446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
    Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
    Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
    Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
    J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes.
    Machida K; Cheng KT; Sung VM; Lee KJ; Levine AM; Lai MM
    J Virol; 2004 Aug; 78(16):8835-43. PubMed ID: 15280491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons.
    Larkin J; Bost A; Glass JI; Tan SL
    J Interferon Cytokine Res; 2006 Dec; 26(12):854-65. PubMed ID: 17238828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered natural killer cell repertoire in Tap-1 mutant mice.
    Ljunggren HG; Van Kaer L; Ploegh HL; Tonegawa S
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6520-4. PubMed ID: 8022815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection.
    Wolter F; Glässner A; Krämer B; Kokordelis P; Finnemann C; Kaczmarek DJ; Goeser F; Lutz P; Nischalke HD; Strassburg CP; Spengler U; Nattermann J
    J Hepatol; 2015 Dec; 63(6):1334-44. PubMed ID: 26297916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.